Pacific Biosciences Of California (PACB) Construction in Progress (2016)
Pacific Biosciences Of California (PACB) recorded quarterly Construction in Progress of $5.8 million in Q4 2016.
Pacific Biosciences Of California (PACB) Construction in Progress (2016) Analysis & Trends
Pacific Biosciences Of California's Construction in Progress history runs 1 years deep, the most recent figure standing at $5.8 million for Q4 2016.
- In Q4 2016, Construction in Progress changed N/A year-over-year to $5.8 million; the TTM figure through Dec 2016 stood at $5.8 million (changed N/A YoY), while the FY2016 annual figure was $5.8 million, changed N/A from the prior year.
- Construction in Progress was $5.8 million for Q4 2016 at Pacific Biosciences Of California.
- In the past five years, Construction in Progress ranged from a high of $5.8 million in Q4 2016 to a low of $5.8 million in Q4 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.12 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 509.50 Mn |
| 10 | Pacific Biosciences Of California | 426.62 Mn | 150.66 Mn | 12.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 5.80 Mn |